[HTML][HTML] Tuberculosis drugs' distribution and emergence of resistance in patient's lung lesions: a mechanistic model and tool for regimen and dose optimization
Background The sites of mycobacterial infection in the lungs of tuberculosis (TB) patients
have complex structures and poor vascularization, which obstructs drug distribution to these …
have complex structures and poor vascularization, which obstructs drug distribution to these …
Tuberculosis drugs' distribution and emergence of resistance in patient's lung lesions: A mechanistic model and tool for regimen and dose optimization
N Strydom, SV Gupta, WS Fox, LE Via, H Bang… - PLoS …, 2019 - search.proquest.com
Background The sites of mycobacterial infection in the lungs of tuberculosis (TB) patients
have complex structures and poor vascularization, which obstructs drug distribution to these …
have complex structures and poor vascularization, which obstructs drug distribution to these …
[PDF][PDF] Tuberculosis drugs' distribution and emergence of resistance in patient's lung lesions: a mechanistic model and tool for regimen and dose optimization
N Strydom, SV Gupta, WS Fox, LE Via… - Infusion & …, 2019 - irbis-nbuv.gov.ua
BaCKGround. The sites of mycobacterial infection in the lungs of tuberculosis (TB) patients
have complex structures and poor vascularization, which obstructs drug distribution to these …
have complex structures and poor vascularization, which obstructs drug distribution to these …
Tuberculosis drugs' distribution and emergence of resistance in patient's lung lesions: a mechanistic model and tool for regimen and dose optimization.
N Strydom, SV Gupta, WS Fox, LE Via… - 2019 - cabidigitallibrary.org
Background: The sites of mycobacterial infection in the lungs of tuberculosis (TB) patients
have complex structures and poor vascularization, which obstructs drug distribution to these …
have complex structures and poor vascularization, which obstructs drug distribution to these …
Tuberculosis drugs' distribution and emergence of resistance in patient's lung lesions: A mechanistic model and tool for regimen and dose optimization
N Strydom, SV Gupta, WS Fox, LE Via, H Bang… - PLoS Medicine, 2019 - go.gale.com
Background The sites of mycobacterial infection in the lungs of tuberculosis (TB) patients
have complex structures and poor vascularization, which obstructs drug distribution to these …
have complex structures and poor vascularization, which obstructs drug distribution to these …
Tuberculosis drugs' distribution and emergence of resistance in patient's lung lesions: A mechanistic model and tool for regimen and dose optimization.
N Strydom, SV Gupta, WS Fox, RM Savic… - PLoS …, 2019 - search.ebscohost.com
Abstract < bold> Background: </bold> The sites of mycobacterial infection in the
lungs of tuberculosis (TB) patients have complex structures and poor vascularization, which …
lungs of tuberculosis (TB) patients have complex structures and poor vascularization, which …
Tuberculosis drugs' distribution and emergence of resistance in patient's lung lesions: A mechanistic model and tool for regimen and dose optimization
N Strydom, SV Gupta, WS Fox, LE Via… - PLoS …, 2019 - pubmed.ncbi.nlm.nih.gov
Background The sites of mycobacterial infection in the lungs of tuberculosis (TB) patients
have complex structures and poor vascularization, which obstructs drug distribution to these …
have complex structures and poor vascularization, which obstructs drug distribution to these …
[PDF][PDF] Tuberculosis drugs' distribution and emergence of resistance in patient's lung lesions: A
N Strydom, SV Gupta, WS Fox - PLoS medicine, 2019 - pdfs.semanticscholar.org
Background The sites of mycobacterial infection in the lungs of tuberculosis (TB) patients
have complex structures and poor vascularization, which obstructs drug distribution to these …
have complex structures and poor vascularization, which obstructs drug distribution to these …
Tuberculosis drugs' distribution and emergence of resistance in patient's lung lesions: A mechanistic model and tool for regimen and dose optimization
N Strydom, SV Gupta, WS Fox, LE Via… - PLoS …, 2019 - researchwithrutgers.com
Background The sites of mycobacterial infection in the lungs of tuberculosis (TB) patients
have complex structures and poor vascularization, which obstructs drug distribution to these …
have complex structures and poor vascularization, which obstructs drug distribution to these …
Tuberculosis drugs' distribution and emergence of resistance in patient's lung lesions: A mechanistic model and tool for regimen and dose optimization.
N Strydom, SV Gupta, WS Fox, LE Via, H Bang… - Plos …, 2019 - europepmc.org
Background The sites of mycobacterial infection in the lungs of tuberculosis (TB) patients
have complex structures and poor vascularization, which obstructs drug distribution to these …
have complex structures and poor vascularization, which obstructs drug distribution to these …